ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 51 filers reported holding ORCHARD THERAPEUTICS PLC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $408 | -59.2% | 1,100 | -6.9% | 0.00% | – |
| Q3 2022 | $1,000 | -96.7% | 1,181 | -97.7% | 0.00% | – |
| Q2 2022 | $30,000 | +114.3% | 50,731 | +164.0% | 0.00% | – |
| Q1 2022 | $14,000 | +600.0% | 19,216 | +1550.9% | 0.00% | – |
| Q4 2021 | $2,000 | -99.4% | 1,164 | -99.2% | 0.00% | – |
| Q3 2021 | $328,000 | -36.9% | 142,755 | +20.5% | 0.00% | – |
| Q2 2021 | $520,000 | +102.3% | 118,483 | +234.7% | 0.00% | – |
| Q1 2021 | $257,000 | +192.0% | 35,401 | +74.6% | 0.00% | – |
| Q4 2020 | $88,000 | +266.7% | 20,277 | +248.1% | 0.00% | – |
| Q3 2020 | $24,000 | -25.0% | 5,825 | +10.1% | 0.00% | – |
| Q2 2020 | $32,000 | -67.0% | 5,291 | -59.1% | 0.00% | – |
| Q1 2020 | $97,000 | +131.0% | 12,933 | +328.4% | 0.00% | – |
| Q4 2019 | $42,000 | – | 3,019 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 5,307,751 | $3,101,000 | 1.18% |
| TANG CAPITAL MANAGEMENT LLC | 2,000,000 | $1,168,000 | 0.18% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $4,060,000 | 0.08% |
| Artal Group S.A. | 1,803,858 | $1,054,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 616,402 | $360,000 | 0.05% |
| RA Capital Management | 3,040,885 | $1,776,000 | 0.05% |
| Forefront Analytics, LLC | 92,641 | $58,000 | 0.03% |
| Temasek Holdings (Private) Ltd | 4,319,049 | $2,523,188 | 0.01% |
| FEDERATED HERMES, INC. | 8,309,859 | $4,853,000 | 0.01% |
| Cormorant Asset Management, LP | 256,649 | $150,000 | 0.01% |